Doctors break down what you need to know about the four-dose vaccine.

A new Lyme disease vaccine made by Pfizer and Valneva could lower infection rates of the tick-borne illness, but federal approval and patient uptake could be a challenge ...

In the world of clinical trials, missing the primary endpoint of a pivotal trial typically spells real trouble for a drug ...

Pharmaceutical giant Pfizer PFE1.28%increase; green up pointing triangle and French vaccine maker Valneva VLA 0.29%increase; green up pointing triangle reported positive topline results from their ...

Michigan has seen cases skyrocket 168% in five years, but the new vaccine candidate offers hope with strong trial results and no safety concerns in participants as young as 5.

A Lyme disease vaccine has shown efficacy in a clinical trial and paves the way for marketing authorisation, pharmaceutical companies Pfizer and the French Valneva announced on Monday. Lyme disease is ...

Pfizer shared an update last week on its clinical trial for VALOR, which is short for "Vaccine Against Lyme for Outdoor Recreationists." The drugmaker said in its report that the vaccine was ...